OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Sysnav Healthcare has developed medical grade wearables based on magneto-inertial technology for 3D movement reconstruction. This enables precise movement tracking without GPS, thus protecting patient privacy while enabling indoor monitoring.
Sysnav Healthcare and Roche have expanded their collaboration across multiple programs to develop meaningful digital endpoints that will monitor disease progression, support clinical trials and serve as regulatory approved standards of outcome measurement. The partnership will also develop the next generation wearable technology to further promote personalised healthcare.
"When high precision technology meets clinical expertise, it is a game-changing combination to accelerate medical progress. Bringing together Sysnav's digital health technology and Roche's expertise in neuroscience drug development and personalised healthcare will enable us to have a truly meaningful impact on patients with motor impairments. By establishing a new set of industry standards for the evaluation of motor impairments, we can unlock innovation for the benefit of all patients," says Damien Eggenspieler, Sysnav Healthcare Program Director.